TP53 and ovarian carcinoma: found that upregulated circNUP50 promotes platinum resistance in ovarian cancer by accelerating p53 ubiquitination through binding to both p53 and UBE2T, as well as by modulating the miR‐197‐3p/G3BP1 axis.